US Edition
News from biotuesdays.com
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top biotuesdays.com News
France · FranceOSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab
Development built on strong IL-7R biological rationale Chronic Pouchitis offers a capital-efficient rare-disease path with fast route to market Hidradenitis Suppurativa enables rapid proof-of-concept in a large dermatology market First Phase 2 clinical trial expected to start in H2 2026, subject to financing Ulcerative Colitis …See the Story
OSE Immunotherapeutics Selects Chronic Pouchitis and Hidradenitis Suppurativa as New Key Indications for Lusvertikimab
100% Center coverage: 1 sources
SoftwareQT Imaging Holdings has announced a new collaboration with Olea Medical to advance cloud-based breast imaging analytics.The post QT Imaging and Olea Medical collaborate on cloud-based breast analytics appeared first on Medical Device Network.See the Story
